Literature DB >> 16476585

Trp-Arg-Trp-Trp-Trp-Trp antagonizes formyl peptide receptor like 2-mediated signaling.

Eun Ha Shin1, Ha-Young Lee, Sang Doo Kim, Seong Ho Jo, Mi-Kyoung Kim, Kyoung Sun Park, Hyuck Lee, Yoe-Sik Bae.   

Abstract

Although formyl peptide receptor like 2 (FPRL2) has been regarded as an important classical chemoattractant receptor, its functional role and signaling pathway have not been fully investigated, because of the lack of its specific ligand. Recently F2L, a heme-binding protein fragment peptide, has been reported as an FPRL2-selective endogenous agonist. In the present study, we examined the effect of Trp-Arg-Trp-Trp-Trp-Trp-CONH2 (WRWWWW, WRW4), on F2L-induced cell signaling. WRW4 inhibited the activation of FPRL2 by F2L, resulting in the complete inhibition of intracellular calcium increase and chemotactic migration induced by F2L. WRW4 also completely inhibited F2L-induced NF-kappaB activation in FPRL2-transfected HEK293 cells. WRW4 specifically inhibited F2L-induced intracellular calcium increase and chemotactic migration in mature monocyte-derived dendritic cells, which express FPRL2 but not the other FPR family. Taken together, WRW4 is the first FPRL2 antagonist and is expected to be useful in the study of FPRL2 signaling and in development of drugs against FPRL2-related cellular responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476585     DOI: 10.1016/j.bbrc.2006.01.098

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence.

Authors:  Maren Rautenberg; Hwang-Soo Joo; Michael Otto; Andreas Peschel
Journal:  FASEB J       Date:  2010-12-23       Impact factor: 5.191

2.  Peptides derived from HIV-1, HIV-2, Ebola virus, SARS coronavirus and coronavirus 229E exhibit high affinity binding to the formyl peptide receptor.

Authors:  John S Mills
Journal:  Biochim Biophys Acta       Date:  2006-06-06

3.  Serum Amyloid A Induces Toll-Like Receptor 2-Dependent Inflammatory Cytokine Expression and Atrophy in C2C12 Skeletal Muscle Myotubes.

Authors:  Samantha L Passey; Steven Bozinovski; Ross Vlahos; Gary P Anderson; Michelle J Hansen
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

4.  microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense.

Authors:  Anna Maria Pierdomenico; Sara Patruno; Marilina Codagnone; Felice Simiele; Veronica Cecilia Mari; Roberto Plebani; Antonio Recchiuti; Mario Romano
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

5.  Peptides from allergenic lipocalins bind to formyl peptide receptor 3 in human dendritic cells to mediate TH2 immunity.

Authors:  Dominik Klaver; Beate Posch; Anita Geisler; Martin Hermann; Norbert Reider; Christine Heufler
Journal:  J Allergy Clin Immunol       Date:  2019-07-19       Impact factor: 10.793

Review 6.  The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.

Authors:  Hui-Qiong He; Richard D Ye
Journal:  Molecules       Date:  2017-03-13       Impact factor: 4.411

Review 7.  Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury?

Authors:  Felicity N E Gavins
Journal:  Trends Pharmacol Sci       Date:  2010-05-17       Impact factor: 14.819

8.  Antimicrobial peptide LL-37 ameliorates a murine sepsis model via the induction of microvesicle release from neutrophils.

Authors:  Yumi Kumagai; Taisuke Murakami; Toshiaki Iba; Johannes Reich; Isao Nagaoka
Journal:  Innate Immun       Date:  2020-06-29       Impact factor: 2.680

9.  Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins.

Authors:  Eleonora Cianci; Antonio Recchiuti; Oriana Trubiani; Francesca Diomede; Marco Marchisio; Sebastiano Miscia; Romain A Colas; Jesmond Dalli; Charles N Serhan; Mario Romano
Journal:  Stem Cells Transl Med       Date:  2015-11-25       Impact factor: 6.940

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.